Importance of Monocyte Chemoattractant Protein-1 Pathway in Neointimal Hyperplasia After Periarterial Injury in Mice and Monkeys

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Circulation Research

• Publication date

  2002-06-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.RES.0000020561.03244.7EPMID 12065319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular Endothelial Growth Factor Is Necessary in the Development of Arteriosclerosis by Recruiting/Activating Monocytes in a Rat Model of Long-Term Inhibition of Nitric Oxide Synthesis

  2002cited by this paper
• Roles of Angiotensin II Type 2 Receptor Stimulation Associated With Selective Angiotensin II Type 1 Receptor Blockade With Valsartan in the Improvement of Inflammation-Induced Vascular Injury

  2001cited by this paper
• Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty

  2001cited by this paper
• Chemokines and disease

  2001cited by this paper
• New Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Atherosclerosis in Apolipoprotein E-Knockout Mice

  2001cited by this paper
• Atherosclerosis The Road Ahead

  2001cited by this paper
• Atherosclerosis : Vascular biology

  2000cited by this paper
• Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats.

  2000cited by this paper
• Inflammation influences vascular remodeling through AT2 receptor expression and signaling.

  2000cited by this paper
• Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice.

  2000cited by this paper
• Role of Monocyte Chemoattractant Protein-1 in Cardiovascular Remodeling Induced by Chronic Blockade of Nitric Oxide Synthesis

  2000cited by this paper
• Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice.

  2000cited by this paper
• Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats.

  2000cited by this paper
• Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits vascular remodeling in rats: blockade of MCP‐1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis

  2000cited by this paper
• Increased Activity of Nuclear Factor-κB Participates in Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide Synthesis in Rats

  2000cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries.

  1999cited by this paper
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

  1998cited by this paper
• Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

  1998cited by this paper
• Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice.

  1998cited by this paper
• Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions.

  1998cited by this paper
• Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.

  1997cited by this paper
• Restenosis revisited--new targets, new therapies.

  1997cited by this paper
• A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer

  1995cited by this paper

• Apolipoprotein C3 Promotes Angiogenesis in an Inflammatory Mouse Model of Peripheral Artery Disease

  2025cites this paper
• Hemodialysis vascular access flow surveillance: Current evidence and future directions

  2025cites this paper
• Harnessing the therapeutic value of Tanshinone IIA: a breakthrough therapy in cardiovascular diseases

  2025cites this paper
• Biophysically stressed vascular smooth muscle cells express MCP-1 via a PDGFR-β-HMGB1 signaling pathway

  2024cites this paper
• Metabolic reprogramming of immune cells by mitochondrial division inhibitor-1 to prevent post-vascular injury neointimal hyperplasia.

  2024cites this paper
• Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling

  2024cites this paper
• Animal models for large vessel vasculitis – The unmet need

  2023cites this paper
• The Mechanisms of Restenosis and Relevance to Next Generation Stent Design

  2022cites this paper
• Targeting smooth muscle cell phenotypic switching in vascular disease

  2021cites this paper
• Inflammatory Chemokines in Atherosclerosis

  2021cites this paper
• Circulating Level of Monocyte Chemoattractant Protein-1 and Risk of Coronary Artery Disease: A Case–Control and Mendelian Randomization Study

  2021cites this paper
• 5-LO-derived LTB4 plays a key role in MCP-1 expression in HMGB1-exposed VSMCs via a BLTR1 signaling axis

  2021cites this paper
• The Multiple Roles of Chemokines in the Mechanisms of Stent Biocompatibility.

  2020cites this paper
• Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease.

  2020cites this paper
• Noncoding RNAs in vascular smooth muscle cell function and neointimal hyperplasia

  2020cites this paper
• Ipragliflozin-induced adipose expansion inhibits cuff-induced vascular remodeling in mice

  2019cites this paper
• In vitro study of human endothelial progenitor cells behaviour on nitrided Ni-free Ti–27Nb alloy

  2019cites this paper
• The Impact of Natural Antioxidants on the Regenerative Potential of Vascular Cells

  2019cites this paper
• Broad‐spectrum chemokine inhibition blocks inflammation‐induced angiogenesis, but preserves ischemia‐driven angiogenesis

  2019cites this paper
• HDL ( High-Density Lipoproteins ) and Apo ( Apolipoprotein ) A-I Improve Stent Biocompatibility Recent Evidence From Experimental Models and Clinical Studies

  2018influential citation
• High-Density Lipoproteins and Apolipoprotein A-I Improve Stent Biocompatibility.

  2018cites this paper
• Microbiota control acute arterial inflammation and neointimal hyperplasia development after arterial injury

  2018cites this paper
• Drug-induced Glomerulonephritis: The Spectre of Biotherapeutic and Antisense Oligonucleotide Immune Activation in the Kidney

  2018cites this paper
• The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development

  2017cites this paper
• Induced Pluripotent Stem Cell‐Derived Endothelial Cells Overexpressing Interleukin‐8 Receptors A/B and/or C‐C Chemokine Receptors 2/5 Inhibit Vascular Injury Response

  2017cites this paper
• Vitronectin and Urokinase-Type Plasminogen Activator Gene Expression Levels Are Increased in Patients with Coronary Artery In-Stent Restenosis

  2017cites this paper
• p115 RhoGEF activates the Rac1 GTPase signaling cascade in MCP1 chemokine–induced vascular smooth muscle cell migration and proliferation

  2017cites this paper
• Vascular Stem/Progenitor Cell Migration and Differentiation in Atherosclerosis

  2017influential citation
• Renal Calcium Oxalate Deposits Induce a Pro‐Atherosclerotic and Pro‐Osteoporotic Response in Mice

  2017cites this paper
• Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell‐Derived Chemokine (C‐C Motif) Ligand 2 and Chemokine (C‐X‐C motif) Ligand 1 Contributes to Neointima Formation

  2016cites this paper
• Synergistic Inhibitory Effect of Rosuvastatin and Angiotensin II Type 2 Receptor Agonist on Vascular Remodeling

  2016cites this paper
• MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation

  2016cites this paper
• Monocyte to HDL ratio in prediction of BMS restenosis in subjects with stable and unstable angina pectoris.

  2016cites this paper
• The combination of valsartan and ramipril protects against blood vessel injury and lowers blood pressure

  2016cites this paper
• sPLA2-IIA Augments Oxidized LDL-Induced MCP-1 Expression in Vitro Through Activation of Akt

  2015cites this paper
• Blockade of CD40–TRAF2,3 or CD40–TRAF6 is sufficient to inhibit pro‐inflammatory responses in non‐haematopoietic cells

  2015cites this paper
• The Role of MCP-1(Monocyte Chemoattractant Protein-1) in Restenosis

  2014cites this paper
• The effect of testosterone on factors associated with diabetes, atherosclerosis and obesity.

  2014cites this paper
• Toll-Like Receptor 4 Mediates Inflammatory Cytokine Secretion in Smooth Muscle Cells Induced by Oxidized Low-Density Lipoprotein

  2014cites this paper
• Damage associated molecular patterns and toll like receptors in inflammation mediated vascular remodeling : mechanistic insights and therapeutic potentials

  2014cites this paper
• Importance of endothelial NF-κB signalling in vascular remodelling and aortic aneurysm formation.

  2013cites this paper
• DNA Enzyme ED5 Depletes Egr-1 and Inhibits Neointimal Hyperplasia in Rats

  2013cites this paper
• Small Animal Models to Study Restenosis and Effects of (Local) Drug Therapy

  2013cites this paper
• Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model.

  2013cites this paper
• Chapter 2 Future potential biomarkers for post-interventional restenosis and accelerated atherosclerosis

  2013cites this paper
• Regression of atherosclerosis plaques in apolipoprotein E-/- mice after lentivirus-mediated RNA interference of CD40.

  2013cites this paper
• Comparison of plasma stromal derived factor-1 alpha levels of patients with obstructive sleep apnea syndrome to people with simple snoring

  2013cites this paper
• Gene delivery strategies targeting stable atheromatous plaque.

  2013cites this paper
• Bindarit, an anti-inflammatory agent, reduces neointimal hyperplasia in animal models of vascular injury

  2013cites this paper
• Circuitry of the adult hippocampal neural stem cell niche.

  2012cites this paper
• Влияние хемокинов на формирование атеросклеротического поражения за счёт регулирования функции

  2012cites this paper
• Key role of PI 3 K g in monocyte chemotactic protein-1-mediated amplification of PDGF-induced aortic smooth muscle cell migration

  2012cites this paper
• Swirling flow can suppress monocyte adhesion in the flow disturbance zones of the endovascular stent

  2012cites this paper
• Future potential biomarkers for postinterventional restenosis and accelerated atherosclerosis.

  2012cites this paper
• Monocyte chemoattractant protein‐1 is associated with silent cerebral infarction in patients on haemodialysis

  2012cites this paper
• The role of perivascular adipose tissue in vascular smooth muscle cell growth

  2012influential citation
• Key role of PI3Kγ in monocyte chemotactic protein‐1‐mediated amplification of PDGF‐induced aortic smooth muscle cell migration

  2012cites this paper
• Endovascular therapy with MCP-1 releasing coils promotes inflammatory intra-aneurysmal tissue healing.

  2012cites this paper
• Effect of a Dipeptidyl Peptidase-IV Inhibitor, Des-Fluoro-Sitagliptin, on Neointimal Formation after Balloon Injury in Rats

  2012cites this paper
• Inhibition of MCP-1/CCR2 signaling pathway is involved in synergistic inhibitory effects of irbesartan with rosuvastatin on vascular remodeling.

  2012cites this paper
• Imatinib mesylate-incorporated nanoparticle-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries.

  2011cites this paper
• CD40 Is Essential in the Upregulation of TRAF Proteins and NF-KappaB-Dependent Proinflammatory Gene Expression after Arterial Injury

  2011cites this paper
• Neural Crest–Derived Stem Cells Migrate and Differentiate Into Cardiomyocytes After Myocardial Infarction

  2011cites this paper
• Curcumin inhibits ox-LDL-induced MCP-1 expression by suppressing the p38MAPK and NF-κB pathways in rat vascular smooth muscle cells

  2011cites this paper
• CD 40 Is Essential in the Upregulation of TRAF Proteins and NF-KappaB-Dependent Proinflammatory Gene Expression after Arterial Injury

  2011cites this paper
• Anti-inflammatory gene therapy for cardiovascular disease.

  2011cites this paper
• Monocyte Chemotactic Protein-1 Promotes Inflammatory Vascular Repair of Murine Carotid Aneurysms via a Macrophage Inflammatory Protein-1&agr; and Macrophage Inflammatory Protein-2–Dependent Pathway

  2011cites this paper
• Gene therapy targeting inflammation in atherosclerosis.

  2011cites this paper
• Differentiation profile of peripheral blood-derived vascular progenitor cell predicts intimal hyperplasia after coronary stenting

  2011cites this paper
• Involvement of Endoplasmic Stress Protein C/EBP Homologous Protein in Arteriosclerosis Acceleration With Augmented Biological Stress Responses

  2011cites this paper
• Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation.

  2011cites this paper
• Chemokines in the vascular inflammatory response of atherosclerosis.

  2010cites this paper
• MCP-1 promotes mural cell recruitment during angiogenesis in the aortic ring model

  2010cites this paper
• The Transcription Factor ETS-1 Mediates Proinflammatory Responses and Neointima Formation in Carotid Artery Endoluminal Vascular Injury

  2010cites this paper
• Oral in vivo bactofection in dextran sulfate sodium treated female Wistar rats.

  2010cites this paper
• The vessel wall: A forgotten player in post thrombotic syndrome

  2010cites this paper
• Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model

  2010cites this paper
• TRAIL Promotes VSMC Proliferation and Neointima Formation in a FGF-2–, Sp1 Phosphorylation–, and NF&kgr;B-Dependent Manner

  2010cites this paper
• Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice.

  2010cites this paper
• Lentivirus-mediated RNAi Targeting CREB Binding Protein Attenuates Neointimal Formation and Promotes Re-endothelialization in Balloon Injured Rat Carotid Artery

  2010cites this paper
• CCR2 antagonists.

  2010cites this paper
• Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases

  2010cites this paper
• Enhanced effect of losartan and rosuvastatin on neointima hyperplasia

  2010cites this paper
• Bedeutung von MCP-1-Serum-Spiegeln und CCR2-Polymorphismen für die endotheliale Funktion in einem Diabetes-Risiko-Kollektiv

  2009cites this paper
• Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease

  2009cites this paper
• Transforming Growth Factor-β Promotes Recruitment of Bone Marrow Cells and Bone Marrow-derived Mesenchymal Stem Cells through Stimulation of MCP-1 Production in Vascular Smooth Muscle Cells*

  2009cites this paper
• Integrative Physiology/Experimental Medicine Soluble Flt-1 Gene Transfer Ameliorates Neointima Formation After Wire Injury in flt-1 Tyrosine Kinase–Deficient Mice

  2009cites this paper
• Realistic Temporal Variations of Shear Stress Modulate MMP-2 and MCP-1 Expression in Arteriovenous Vascular Access

  2009cites this paper
• A critical role of COX-2 in the progression of neointimal formation after wire injury in mice

  2009cites this paper
• Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications.

  2009cites this paper
• Chronic intake of a high-cholesterol diet resulted in hepatic steatosis, focal nodular hyperplasia and fibrosis in non-obese mice

  2009cites this paper
• Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.

  2009cites this paper
• DISSECTING NEUROFIBROMATOSIS TYPE 1 RELATED VASCULOPATHY

  2009cites this paper
• VEGF and restenosis: the rest of the story.

  2009cites this paper
• Nanoparticle-Mediated Delivery of Nuclear Factor &kgr;B Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension

  2009cites this paper
• Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and mice.

  2008cites this paper
• Apolipoprotein E-/- mice have delayed skeletal muscle healing after hind limb ischemia-reperfusion.

  2008cites this paper
• Chemokines in Atherosclerosis , Thrombosis , and Vascular Biology Series

  2008cites this paper
• Mechanisms of arterial remodeling and neointima formation: an updated view on the chemokine system

  2008cites this paper
• Inflammation in injury-induced vascular remodelling : functional involvement and therapeutical options

  2008cites this paper